John Buse, MD, PhD UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans. CHAPEL HILL, NC – More than two-thirds of all type-2 diabetes patients...

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations (PESRAMHIP) UNC Principal Investigator: Tamera Coyne-Beasley, MD, MPH Project Budget: $13,857,788 over 5 years The North Carolina Network...

(Chapel Hill, N.C. — Feb. 24, 2016) — In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells that destroy brain tumors known as glioblastoma...

When Terry Magnuson walked onto the UNC-Chapel Hill campus in 2000, he knew he’d arrived at a unique environment for researchers. “My first day on campus is when I realized this is the place I want to be,” Magnuson,...

Milele Bynum capped her long journey from medical school to motherhood and back again with a national award for the success of her community health program. Milele Bynum presents her research at Student Research Day More...

Melina Kibbe, MD, has been appointed the Zach D. Owens Distinguished Professor and Chair of the Department of Surgery. Kibbe will join the UNC community on July 1. Anthony Meyer, MD, PhD, announced in April of 2015 that...

The Obama administration is moving ahead with a major project to learn how to better tailor treatments and preventive care to people's genes, environment and lifestyle. As part of the Precision Medicine Initiative, the...

Every day Americans decide to take medicines and try prevention and treatment options, based on health care providers' recommendations, which are often informed through clinical trials. While we might notice that a medicine’s...

Dr. Shawn Hingtgen (photo: Dan Sears) (Chapel Hill, N.C. — Feb. 24, 2016) — In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells...

NC TraCS' KL2 Scholar Shawn Hingtgen co-authors paper on tumour-homing stem cells Dr. Shawn Hingtgen (photo: Dan Sears) Abstract Transdifferentiation (TD) is a recent advancement in somatic cell reprogramming. The direct...